about
Peptide substrates for Rho-associated kinase 2 (Rho-kinase 2/ROCK2)A short peptide is a protein kinase C (PKC) alpha-specific substrate.Letter: correlation between phosphorylation ratios by matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis and enzyme kinetics.Plasma protein kinase C (PKC)alpha as a biomarker for the diagnosis of cancers.Monitoring of phosphorylated peptides by radioactive assay and matrix-assisted laser desorption-ionization time-of-flight mass spectrometry.Spatiotemporally photoradiation-controlled intratumoral depot for combination of brachytherapy and photodynamic therapy for solid tumorProtein polymer hydrogels by in situ, rapid and reversible self-gelation.Potential new chemotherapy strategy for human ovarian carcinoma with a novel KSP inhibitor.Expression and characterization of myristoylated preS1-conjugated nanocages for targeted cell delivery.Reversal of efflux of an anticancer drug in human drug-resistant breast cancer cells by inhibition of protein kinase Cα (PKCα) activity.Liver cell-specific peptides derived from the preS1 domain of human hepatitis B virus.Tumor therapy by gene regulation system responding to cellular signal.Cellular signal-specific peptide substrate is essential for the gene delivery system responding to cellular signals.Design of polymeric carriers for cancer-specific gene targeting: utilization of abnormal protein kinase Calpha activation in cancer cells.Regulation of Transgene Expression in Tumor Cells by Exploiting Endogenous Intracellular Signals.Rheological properties of cysteine-containing elastin-like polypeptide solutions and hydrogels.Reduction of inorganic phosphate-induced human smooth muscle cells calcification by inhibition of protein kinase A and p38 mitogen-activated protein kinase.Hepatoma-targeted gene delivery using a tumor cell-specific gene regulation system combined with a human liver cell-specific bionanocapsule.Drug delivery system based on responses to an HIV infectious signal.Inflammatory cell-specific transgene expression system responding to Ikappa-B kinase beta activation.Direct measure of fluorescence intensity for efficient receptor-binding assay: conjugates of ethinylcarboxyestradiol and 5(and 6)-carboxyfluorescein via alpha, omega-diaminoalkanes as a tracer for estrogen receptor.In situ depot formation of anti-HIV fusion-inhibitor peptide in recombinant protein polymer hydrogel.Molecular mechanism of caspase-3-induced gene expression of polyplexes formed from polycations grafted with cationic substrate peptides.Role of amino acid residues surrounding the phosphorylation site in peptide substrates of G protein-coupled receptor kinase 2 (GRK2).Peptide substrates for G protein-coupled receptor kinase 2.Structural requirements of para-alkylphenols to bind to estrogen receptor.Pathogenic Viruses Commonly Present in the Oral Cavity and Relevant Antiviral Compounds Derived from Natural ProductsStructural essentials of xenoestrogen dialkyl phthalates to bind to the estrogen receptorsBinding characteristics of dialkyl phthalates for the estrogen receptorRole of plasma as activator and cofactor in phosphorylation catalyzed by protein kinase CDirect, real-time, simultaneous monitoring of intravitreal nitric oxide and oxygen in endotoxin-induced uveitis in rabbitsA high-affinity peptide substrate for G protein-coupled receptor kinase 2 (GRK2)Injectable Polypeptide Hydrogel Depot System for Assessment of the Immune Response-Inducing Efficacy of Sustained Antigen Release Alone
P50
Q28476345-B7F70E44-C5F9-4B2A-992E-64B4199B7A13Q33329609-08A54563-E17E-416A-88C3-2C0312D7AE1EQ33364702-13E636A0-A3BC-4FDE-9EFA-B6F890F26A82Q33497100-E6BD50D7-EDBB-4D9B-A6D1-F37FBAEE03B2Q35664586-1F70317E-E238-4D1A-AA12-F6794F3B77A3Q36421133-23A694D0-FC8B-430F-BD1A-8A11186200C3Q37241141-D7154EE5-DCFD-4D32-9205-79803E2D15F3Q38872271-CE62F56A-D223-4064-87CD-A27EF28A551EQ38929833-9E51759E-056B-4D9E-81AB-00D8AA696913Q38968952-360CAC26-2B2F-473A-B86C-C0260B14751DQ39020923-674FEFC4-6F78-4221-9C31-8335063A30B4Q39665003-0C60E3F0-B78F-49CB-90DF-63BAAC986532Q39791930-C78FA734-E342-4A66-82C4-4E29DC45BC2BQ39928301-EB6FF07C-2FB0-4263-A204-E3816DE1DC83Q41533761-8DE70AEC-D463-484E-9AF9-E6CB29837DD3Q41836968-49BC85A2-1183-464C-A0F1-0BB2A6490EA4Q44219821-101934EB-C53B-45EF-B6FC-5C93A9D3A310Q45856837-7676C345-805A-4F2C-B836-663E20220327Q45879382-787D3A23-6466-48D4-92A9-C32668924927Q45885023-E21FD2DB-0B4E-43B6-B76B-E5D9ADDF5B8EQ46721276-2B55F7D6-B0D8-4A7F-BDA1-0BA36D976F7AQ47610708-638E2305-7949-4877-8D55-8C55FA3927CDQ47767932-27AE3EEA-E95A-478E-9675-B77C487CC36AQ51420740-C8C9D917-66A1-4273-8285-880AC99D8B3EQ53555154-3FE25680-BB34-45C3-8352-06EB1370E204Q54259305-52B6D797-34FA-42F0-BE0A-862BE60FAF4BQ59351133-5A2BFCAC-D486-4A13-BF99-A25AE2C262B8Q73343148-1C14FFFB-2291-4745-93AF-67E4CB479949Q77905966-3096A386-6796-4036-9B38-DB637150E5EFQ79762463-3FFBE2B0-6A92-44C9-B9AA-A2E91D6E33ACQ79781204-30993D1F-933A-4418-B0AE-53E894B13BE7Q90026240-838A705F-24E0-4716-BBB8-A4EA07728C66Q92725466-1187CD79-F27A-4ED9-98F4-B0EAB10E3598
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daisuke Asai
@ast
Daisuke Asai
@en
Daisuke Asai
@es
Daisuke Asai
@nl
type
label
Daisuke Asai
@ast
Daisuke Asai
@en
Daisuke Asai
@es
Daisuke Asai
@nl
prefLabel
Daisuke Asai
@ast
Daisuke Asai
@en
Daisuke Asai
@es
Daisuke Asai
@nl
P106
P1153
14919144700
P31
P496
0000-0003-4015-6694